Pain as a Clinical Problem

Jul 15, 2018 by in Uncategorized Comments Off on Pain as a Clinical Problem

Commentary: Breaking Tradition and Breaking New Ground: The Contributions of WE Fordyce to the Evolution of Pain Theory and Practice Michael J.L. Sullivan, PhD and Michael Nicholas, PhD In this…

read more

Attention and Social Responsiveness

Jul 9, 2018 by in Uncategorized Comments Off on Attention and Social Responsiveness

FIGURE 1 Recording exercise quotas and performance. Diaries. Diary forms will have already been completed during the preadmission evaluation phase and so will be familiar. Diary recording continues in the…

read more

Treatment Goals

Jul 9, 2018 by in Uncategorized Comments Off on Treatment Goals

Commentary: Targeting Behavior Change in Chronic Pain Treatment: A Clinical Perspective James E. Moore, Ph.D. In this chapter, Fordyce focuses on observable pain and well behaviors as treatment goals rather…

read more

Distorted Gait—A Problem of Shaping

Jul 9, 2018 by in Uncategorized Comments Off on Distorted Gait—A Problem of Shaping

FIGURE 1 Increasing walking speed to inhibit knee buckling. Commentary: Distorted Gait: Biomechanical Implications, Historical Reflections, and Future Directions Steven Z. George and Mark D. Bishop It is a great…

read more

The Behavioral Analysis of Pain

Jul 9, 2018 by in Uncategorized Comments Off on The Behavioral Analysis of Pain

FIGURE 1 Schematic criteria for patient selection It is also difficult medically to assess how much pain or functional limitation can reasonably be expected from a given type or amount…

read more

Patient and Spouse Orientation

Jul 9, 2018 by in Uncategorized Comments Off on Patient and Spouse Orientation

FIGURE 1. Usual exercise method (work to tolerance) and operant method (work to quota) Let me take a moment to apply those rules to pain problems. That way you can…

read more

Managing Pain Medications

Jul 9, 2018 by in Uncategorized Comments Off on Managing Pain Medications

or original amount. A 3-day R is decreased by 64 3 3 or 192 mg.   R/ to pharmacists: Demerol, 1728 mg     Bevisol, Plebex, or other liquid B…

read more

Patient Selection

Jul 9, 2018 by in Uncategorized Comments Off on Patient Selection

Commentary: Patient Selection – Setting the Stage for Operant Treatment Warren R. Nielson In Chapter 7, Fordyce [18] defines the necessary patient selection criteria for operant treatment and describes key…

read more
Get Clinical Tree app for offline access